Immune Cell Engineering Market, By Cell Type, By Product, By Disease Indication, By Application, By End User, By Geography

Description

Immune Cell Engineering Market is estimated to be valued at USD 4.23 Bn in 2025 and is expected to reach USD 17.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 22.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 4.23 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	22.50%	2032 Value Projection:	USD 17.51 Bn

Immune cell engineering is a field that has gained significant attention in recent years due to its potential to revolutionize the treatment of various diseases, including cancer. It involves the manipulation and modification of immune cells to enhance their ability to target and destroy cancer cells or other pathogens. This emerging field combines principles of immunology, molecular biology, and genetic engineering to develop innovative therapies.

The immune system plays a critical role in recognizing and eliminating foreign invaders or abnormal cells in the body. However, in some cases, the immune response may be insufficient or ineffective against certain diseases. By genetically modifying immune cells, scientists can enhance their ability to recognize and attack specific targets, such as cancer cells.

Market Dynamics:

The immune cell engineering market is driven by several key factors. Firstly, there is a growing prevalence of various diseases, including cancer, autoimmune disorders, and infectious diseases. As traditional treatment options for these diseases often have limitations, there is a need for innovative therapeutic approaches.

Secondly, advancements in gene-editing technologies have significantly improved the efficiency and precision of immune cell engineering. Gene-editing tools such as CRISPR/Cas9 have made it easier to modify immune cells and enhance their therapeutic potential. These technological innovations are expected to drive the growth of the immune cell engineering market.

However, there are also several challenges and restraints that need to be addressed. One of the main challenges is the high cost associated with immune cell engineering therapies. The development and manufacturing processes for these therapies are complex and require specialized facilities and expertise. This has limited the accessibility of these therapies, particularly in developing countries.

For instance, in December 2022, Gilead Sciences, Inc., a pharmaceutical company, announced the acquisition of Tmunity Therapeutics Inc., a clinical-stage biotechnology company. The acquisition provided Gilead Sciences, Inc. with preclinical and clinical programs, including an "armored" CAR T technology platform that has the potential to be applied to a variety of CAR T cells to enhance anti-tumor activity, and helps to enhance manufacturing processes for of CAR T cells product.

Key features of the study:

This report provides in-depth analysis of the global immune cell engineering market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global immune cell engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza, Miltenyi Biotec, Takara Bio Inc., Sartoroius CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technologies, Inc., Bio-Techne, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Charles River Laboratories, Creative Bioarray, Sartorius AG, Novogene Co, Ltd., AGC Biologics, Catalent, Inc., WuXi AppTec, Discovery Life Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global immune cell engineering market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immune cell engineering market

Detailed Segmentation:

Global Immune Cell Engineering Market, By Cell Type
- T Cells
- NK Cells
- Dendritic Cells
- Tumor Cells
- Stem Cells
- Others
Global Immune Cell Engineering Market, By Product
- Consumables
- Instruments
- Software
Global Immune Cell Engineering Market, By Disease Indication
- Cardiovascular Diseases
- Respiratory Diseases
- Infectious Diseases
- Cancer
- Neurological Diseases
- Others
Global Immune Cell Engineering Market, By Application
- Research Applications
- Cell Therapy & Regenerative Medicine
- Others
Global Immune Cell Engineering Market, By End User
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Academic & Research Institutes
- Cell Banks
- Others
Global Immune Cell Engineering Market, By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Lonza
- Miltenyi Biotec
- Takara Bio Inc.
- Sartoroius CellGenix GmbH
- FUJIFILM Irvine Scientific
- Agilent Technologies, Inc.
- Bio-Techne
- Bio-Rad Laboratories, Inc.
- Becton, Dickinson and Company
- Charles River Laboratories
- Creative Bioarray
- Sartorius AG
- Novogene Co, Ltd.
- AGC Biologics
- Catalent, Inc
- WuXi AppTec
- Discovery Life Sciences

Product Code: CMI6350

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Immune Cell Engineering Market, By Cell Type
- Market Immune Cell Engineering Market, By Product
- Market Immune Cell Engineering Market, By Disease Indication
- Market Immune Cell Engineering Market, By Application
- Market Immune Cell Engineering Market, By End User
- Market Immune Cell Engineering Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Immune Cell Engineering Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Immune Cell Engineering Market, By Cell Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
T Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
NK Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Dendritic Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Tumor Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Immune Cell Engineering Market, By Product, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Immune Cell Engineering Market, By Disease Indication, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Respiratory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Neurological Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Immune Cell Engineering Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cell Therapy & Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Immune Cell Engineering Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cell Banks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

10. Immune Cell Engineering Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Thermo Fisher Scientific,Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sartoroius CellGenix GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
FUJIFILM Irvine Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Agilent Technologies,Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bio-Techne
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Creative Bioarray
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sartorius AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novogene Co, Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AGC Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Catalent, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Discovery Life Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

12. Section

Research Methodology
About us